id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-D-0137-0045,FDA,FDA-2009-D-0137,Use of Serological Tests to Reduce the Risk of Transmission of  Trypanosoma cruzi Infection in Blood and Blood Components; Guidance for Industry; Availability,Notice,Notice of Availability,2017-12-06T05:00:00Z,2017,12,2017-12-06T05:00:00Z,,2017-12-06T15:20:12Z,2017-26226,0,0,0900006482ce90a2
FDA-2009-D-0137-0046,FDA,FDA-2009-D-0137,Use of Serological Tests to Reduce the Risk of Transmission of Trypanosoma cruzi Infection in Blood and Blood Components Guidance for Industry,Other,Guidance,2017-12-06T05:00:00Z,2017,12,2017-12-06T05:00:00Z,,2024-11-07T01:13:38Z,,1,0,0900006482ce9dc0